Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Prediction of survival in head and neck cancer based on leukocyte sedimentation in Ficoll-Hypaque gradients.
[AUTORADIOGRAPHIC STUDIES OF SKIN TRANSPLANTATION].
Endocarditis Due to Cardiobacterium hominis in a 4-Year-Old Boy, Complicated by Right Lower Lobe Pulmonary Artery Mycotic Aneurysm.
Raman spectroscopy as a diagnostic tool for monitoring acute nephritis.
First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Stadler, Walter M.
One or more keywords matched the following items that are connected to
Stadler, Walter M.
Item Type
Name
Concept
Research Design
Academic Article
Development of target-based antineoplastic agents.
Academic Article
Angiogenesis inhibitors.
Academic Article
Clinical trial designs for cytostatic agents.
Academic Article
Randomized discontinuation design: application to cytostatic antineoplastic agents.
Academic Article
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
Academic Article
Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development.
Academic Article
Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Academic Article
Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design.
Academic Article
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Academic Article
Resampling phase III data to assess phase II trial designs and endpoints.
Academic Article
Randomized phase II trials: a long-term investment with promising returns.
Academic Article
A trial postmortem: challenges in conducting a randomized, double-blind, phase 2 study in men with castration-resistant prostate cancer.
Academic Article
Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma.
Academic Article
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
Search Criteria
Research Design